PA-21-259, sbir, phase I, rapid molecular diagnostic assay for detection of candida auris at point of care
Ended Formula Grant Awarded Last action
- Award ID
- R43CK000699
- Recipient
-
Varigen Biosciences Corp UEI XLMBJ8BVWPZ3
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $504,470
Award facts
- Assistance listing
- 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance
- Completion date
- Originally
- Funding agency
- Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- Middleton, WI, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $252,235 | |
| Original award | $252,235 |
Quick answers
Who received award R43CK000699?
R43CK000699 was awarded to Varigen Biosciences Corp by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2023.
How much is award R43CK000699 worth?
$504,470 has been obligated on R43CK000699.
Which agency awarded R43CK000699?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43CK000699, with funding from Office of the Director (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award